Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-11-20 00:00:00 ET · period of report 2025-11-18 · accession 0001193210-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-20 | 2025-11-18 | JAZZ | COZADD BRUCE C | Dir | S - Sale | $181.09 | -18.0K | 397.1K | -4% | -$3.26M |
| 2025-11-20 | 2025-11-20 | JAZZ | COZADD BRUCE C | Dir | A - Grant | $0.00 | +2,506 | 393.3K | +0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-11-18 | S | D | 3,384 | $180.09 | 405,442 | D | — | — | (F1) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $179.4013 to $180.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2025-11-18 | S | D | 5,517 | $181.81 | 391,543 | D | — | — | (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $181.41 to $182.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 3 | Common | Ordinary Shares | 2025-11-18 | S | D | 717 | $182.60 | 390,826 | D | — | — | (F4) Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $181.59 to $182.77. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 4 | Common | Ordinary Shares | 2025-11-20 | A | A | 2,506 | $0.00 | 393,332 | D | — | — | |
| 5 | Common | Ordinary Shares | 2025-11-18 | S | D | 8,382 | $180.88 | 397,060 | D | — | — | (F2) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $180.4028 to $181.385. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |